DK552581A - Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf - Google Patents

Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf

Info

Publication number
DK552581A
DK552581A DK552581A DK552581A DK552581A DK 552581 A DK552581 A DK 552581A DK 552581 A DK552581 A DK 552581A DK 552581 A DK552581 A DK 552581A DK 552581 A DK552581 A DK 552581A
Authority
DK
Denmark
Prior art keywords
pyridylaclyl
preparing
procedure
acceptable salts
pharmaceutical acceptable
Prior art date
Application number
DK552581A
Other languages
Danish (da)
English (en)
Inventor
P E Cross
R P Dickinson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK552581A publication Critical patent/DK552581A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DK552581A 1980-12-15 1981-12-14 Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf DK552581A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8040081 1980-12-15

Publications (1)

Publication Number Publication Date
DK552581A true DK552581A (da) 1982-06-16

Family

ID=10517993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK552581A DK552581A (da) 1980-12-15 1981-12-14 Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf

Country Status (22)

Country Link
US (1) US4363912A (el)
EP (1) EP0054417B1 (el)
JP (1) JPS57181082A (el)
KR (1) KR830007552A (el)
AR (1) AR229110A1 (el)
AU (1) AU525296B2 (el)
CA (1) CA1143737A (el)
CS (1) CS228527B2 (el)
DD (1) DD202290A5 (el)
DE (1) DE3167879D1 (el)
DK (1) DK552581A (el)
ES (1) ES8308872A1 (el)
FI (1) FI814003L (el)
GR (1) GR76355B (el)
IE (1) IE51949B1 (el)
IL (1) IL64534A0 (el)
NO (1) NO814264L (el)
PH (1) PH17576A (el)
PL (1) PL133634B1 (el)
PT (1) PT74123B (el)
YU (1) YU293481A (el)
ZA (1) ZA818665B (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
US4460777A (en) * 1981-11-19 1984-07-17 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4478842A (en) * 1981-11-19 1984-10-23 Ciba-Geigy Corporation N-Substituted-2-pyridylindoles
US4536505A (en) * 1983-05-17 1985-08-20 Ciba-Geigy Corporation Certain N-(pyridyl) indoles
US4511573A (en) * 1983-05-17 1985-04-16 Ciba-Geigy Corporation 3-Substituted-2-(heteroaryl) indoles
GB8524157D0 (en) * 1984-10-19 1985-11-06 Ici America Inc Heterocyclic amides
US4609733A (en) * 1984-12-27 1986-09-02 Ciba-Geigy Corporation 3-keto-substituted-N-pyridylindoles
GB8609175D0 (en) * 1986-04-15 1986-05-21 Ici America Inc Heterocyclic carboxamides
AU774929B2 (en) * 1998-03-31 2004-07-15 Institutes For Pharmaceutical Discovery, Llc, The Substituted indolealkanoic acids
TNSN99224A1 (fr) 1998-12-01 2005-11-10 Inst For Pharm Discovery Inc Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
AU2001232785A1 (en) * 2000-01-14 2001-07-24 The Institutes For Pharmaceutical Discovery, Llc Methods for lowering uric acid levels
DE60306547T2 (de) * 2002-12-10 2007-06-28 Wyeth Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen-aktivator
GB0324763D0 (en) * 2003-10-23 2003-11-26 Oxagen Ltd Use of compounds in therapy
SI2046740T1 (sl) 2006-07-22 2012-12-31 Oxagen Limited Spojine s crth2 antagonistiäśno aktivnostjo
WO2009042485A1 (en) * 2007-09-24 2009-04-02 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
RU2503672C2 (ru) 2008-01-18 2014-01-10 Оксаген Лимитед Соединения, обладающие активностью антагонистов crth2
US7750027B2 (en) * 2008-01-18 2010-07-06 Oxagen Limited Compounds having CRTH2 antagonist activity
US8168673B2 (en) * 2008-01-22 2012-05-01 Oxagen Limited Compounds having CRTH2 antagonist activity
JP2011509990A (ja) 2008-01-22 2011-03-31 オキサジェン リミテッド Ｃｒｔｈ２アンタゴニスト活性を有する化合物
GB201322273D0 (en) 2013-12-17 2014-01-29 Atopix Therapeutics Ltd Process
GB201407820D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form
GB201407807D0 (en) * 2014-05-02 2014-06-18 Atopix Therapeutics Ltd Polymorphic form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5173M (el) * 1966-02-11 1967-06-19
FR7337M (el) * 1968-01-11 1969-10-13
GB2045244B (en) 1979-03-07 1983-01-26 Pfizer Ltd 3-1-(imidazolylalkyl) indoles
US4322533A (en) * 1980-03-17 1982-03-30 Lesher George Y 1H-Indole-2,3-dione derivatives

Also Published As

Publication number Publication date
EP0054417B1 (en) 1984-12-19
PT74123A (en) 1982-01-01
PL133634B1 (en) 1985-06-29
ZA818665B (en) 1982-10-27
DE3167879D1 (en) 1985-01-31
CA1143737A (en) 1983-03-29
IE812928L (en) 1982-06-15
YU293481A (en) 1984-10-31
AU525296B2 (en) 1982-10-28
NO814264L (no) 1982-06-16
CS228527B2 (en) 1984-05-14
ES507960A0 (es) 1983-10-01
IL64534A0 (en) 1982-03-31
FI814003L (fi) 1982-06-16
PH17576A (en) 1984-10-01
JPS57181082A (en) 1982-11-08
IE51949B1 (en) 1987-04-29
PT74123B (en) 1983-12-19
KR830007552A (ko) 1983-10-21
US4363912A (en) 1982-12-14
AR229110A1 (es) 1983-06-15
AU7848881A (en) 1982-06-24
GR76355B (el) 1984-08-06
DD202290A5 (de) 1983-09-07
ES8308872A1 (es) 1983-10-01
EP0054417A1 (en) 1982-06-23
PL234253A1 (en) 1983-05-23

Similar Documents

Publication Publication Date Title
DK331881A (da) Fremgangsmaade til fremstilling af trisubstituerede imidazolderivater eller salte deraf
DK160940C (da) Analogifremgangsmaade til fremstilling af benzoheterocycliske forbindelser eller farmaceutisk acceptable salte deraf
DK552581A (da) Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf
DK28282A (da) Fremgangsmaade til fremstilling af hexapyranoseforbindelser eller salte deraf
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK405881A (da) Fremgangsmaade til fremstilling af 7beta-aminothiadiazolylacetylamino3-ammoniomethyl-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK158306C (da) Analogifremgangsmaade til fremstilling af substituerede pyridylallylforbindelser eller farmaceutisk acceptable salte deraf
DK297382A (da) Fremgangsmaade til fremstilling af 3-(3-(heteroarylalkyl)-1-indolyl)acryl-syre-derivater eller farmaceutisk acceptable salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK413883D0 (da) Fremgangsmade til fremstilling af c-20-modificerede macrolid-derivater eller farmaceutisk acceptable salte deraf
DK358183D0 (da) Fremgangsmade til fremstilling af alfa-aryl-alkansyrer eller salte deraf
DK475982A (da) Fremgangsmaade til fremstilling af benzofuranoner eller salte deraf
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK365980A (da) Fremgangsmaade til fremstilling af 7-betaaminothiadiazolylacetylamino-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK152491C (da) Analogifremgangsmaade til fremstilling af esterholdige phenoxypropanolaminer eller farmaceutisk anvendelige salte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK366081A (da) Fremgangsmaade til fremstilling af diaryl-imidazol-forbindelser eller salte deraf
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK210183A (da) Fremgangsmaade til fremstilling af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK432582A (da) Fremgangsmaade til fremstilling af aminooxazolylforbindelser eller salte deraf
DK109781A (da) Fremgangsmaade til fremstilling af 7-betaaminoisothiazolylacetamido-3-cephem-4-carboxylsyreforbindelser eller salte deraf
DK556581A (da) Fremgangsmaade til fremstilling af aminopapulacadin-derivater eller salte deraf

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment